In 2023, an advisory panel of clinicians and researchers reviewed every major category of non-hormonal menopause treatment for The Menopause Society's position statement — placebo-controlled trials, Cochrane reviews, meta-analyses. Most categories failed. Not "need more research" failed: graded not-recommended at Level I or II evidence failed.

Mayo Clinic's patient guidance says it plainly: "There are many alternative medicines that claim to help ease the symptoms of menopause. But few of them have been proved in studies."

The skip list

TreatmentGradeWhat the trials showed
Herbal supplements — black cohosh, evening primrose, and friendsLevels I–IINo reliable separation from placebo; unregulated quality and dosing compound the problem.
Paced respiration as a treatmentLevel IThe most surprising entry: the best-known "natural technique" failed at the highest evidence grade. Breathing may help you through a flash's moment — it does not reduce flashes.
Cooling devices & wearablesLevel IIA 39-woman randomized crossover trial of a nighttime thermal-comfort device found no objective change in nighttime flashes — only subjective comfort.
Soy foods/extracts & equol supplementsLevel IIFoods containing phytoestrogens haven't been shown to ease flashes in trials; weak estrogen-like effects warrant caution after breast cancer.
Trigger avoidance (caffeine, alcohol, spicy food)Level IIIntuitive, widely repeated, never tested in a clinical trial.
Cannabinoids (CBD/THC)Level IIAggressively marketed; no controlled evidence for vasomotor symptoms.
Exercise or yoga as flash treatmentLevel IICochrane reviews pooled multiple RCTs: no effect on flash frequency. (See nuance below.)
Mindfulness-based interventions for VMSLevel IIPositive effects on general wellbeing; mixed-to-null on flashes specifically.
AcupunctureLevel IIConsistently fails to beat sham needling in controlled designs.
"Menopause diets"Level IIINo clinical-trial support for symptom relief via dietary modification.
Compounded "bioidentical" hormonesSafetyNot a supplement issue but worth including: insufficient safety/efficacy data, no regulatory oversight, overdosing risk. Regulator-approved body-identical products exist.
The exercise nuance: exercise fails narrowly as a hot-flash treatment. For bone density — which drops fastest right after the final period — high-intensity strength and impact training has meta-analytic support. For mood, sleep architecture, and cardiovascular risk, it remains first-line advice. Don't let one failed indication erase the others.

Why does this market survive?

Three forces keep failed treatments on shelves:

  1. Placebo response rates of 20–66%. Hot flashes genuinely improve with attention and expectation. Any uncontrolled testimonial — "it worked for me!" — is indistinguishable from placebo at these rates.
  2. Natural fluctuation. Symptoms wax and wane over months. Whatever you started taking during a bad patch gets credited when the wave passes.
  3. Supplements aren't drugs, legally. Pre-market efficacy testing isn't required, so the burden of proof falls on academic researchers funded by grants — years behind the marketing cycle.

The two-minute credibility check

Before buying any menopause product, ask three questions:

  1. Sham-controlled? A trial against a fake version of itself (sugar pill, sham acupuncture, white-noise audio) is the only kind that counts here.
  2. Objective endpoint? Did the study measure flash frequency with monitors or diaries — or just "how did you feel?"
  3. Who profits from the claim? The company selling it, or researchers with nothing to gain?

If any answer is wrong, you're looking at the gold rush — not medicine. The treatments that do clear this bar are covered in our cornerstone guide.

Frequently asked questions

Does black cohosh work for hot flashes?
No — graded not-recommended at Levels I–II in the 2023 systematic review. Trials find no reliable benefit over placebo.
Do cooling devices help night sweats?
A randomized crossover trial found no objective reduction in nighttime flash number or duration — only subjective comfort. Graded not-recommended (Level II).
Isn't exercise good for menopause overall?
Very much so — for bone, heart, mood, and sleep. It's only "not recommended" as a specific hot-flash treatment, where trials show no frequency reduction.
What about bioidentical hormones from compounding pharmacies?
Different problem, same caution: insufficient safety and efficacy data, no regulatory oversight, dosing variability. Regulator-approved body-identical hormone products exist if hormones are appropriate for you.

References

  1. The Menopause Society. Nonhormonal Management of Menopause-Associated Vasomotor Symptoms: 2023 Position Statement. Menopause. 2023.
  2. Mayo Clinic. Menopause — Diagnosis and treatment. Accessed August 2026.
  3. Bloomberg. "The Menopause Gold Rush Is Failing Women." July 23, 2026.
  4. The Menopause Society. The 2022 Hormone Therapy Position Statement. Menopause. 2022.
Educational content — not medical advice. Summarizes published systematic reviews for general information. Individual care decisions require a qualified clinician. Last reviewed August 2026.